Theseus Pharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Theseus Pharmaceuticals, Inc. quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q3 2023.
  • Theseus Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.